$15.15
+0.1000 (+0.664%)
At Close: Jul 31, 2026
Royce Global Trust (NYSE: RGT) as of Jun 30, 2025
04:01pm, Wednesday, 30'th Jul 2025
NEW YORK , July 30, 2025 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 64,166 shares Fund's advise
RGT: Deep Discount On Global Small-Caps But Unappealing Distribution Policy
10:31am, Sunday, 06'th Jul 2025
Royce Global Trust (RGT) offers unique global small-cap exposure in a closed-end fund wrapper. The fund trades at a deep discount, but it is no bargain, as this is a regular occurrence. One of the rea
Royce Global Trust (NYSE: RGT) as of Mar 31, 2025
02:24pm, Thursday, 24'th Apr 2025
NEW YORK , April 24, 2025 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 94,690 shares Fund's advis
Argent BioPharma Enters Germany - Europe's Largest Market
07:00pm, Wednesday, 23'rd Apr 2025
Strategic Expansion Paired with Over $1M in Annual Cost Savings from Operational Restructuring PERTH, Australia , April 23, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF), a cli
Royce Global Trust (NYSE: RGT) as of Feb 28, 2025
02:00pm, Thursday, 27'th Mar 2025
NEW YORK , March 27, 2025 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 33,066 shares Fund's advis
Argent BioPharma Expands Pipeline with Promising Drug CimetrA®
06:00pm, Sunday, 16'th Mar 2025
PERTH, Australia , March 16, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative t
Argent BioPharma Ltd. Updates on SINTEF Collaboration for Chronic Wound Management
05:30pm, Wednesday, 12'th Feb 2025
Advanced wound care market projected to exceed $15 billion globally by 2030 PERTH, Australia , Feb. 12, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX: RGT) (OTCQB: RGTLF) has made significant progr
Royce Global Trust (NYSE: RGT) as of Dec 31, 2024
02:48pm, Monday, 27'th Jan 2025
NEW YORK , Jan. 27, 2025 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 72,971 shares Fund's advi
Argent BioPharma Ltd. Raised US$4,500,000
06:23am, Tuesday, 07'th Jan 2025
PERTH, Australia , Jan. 7, 2025 /PRNewswire/ -- Argent BioPharma (ASX:RGT) (OTCQB:RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatments
Argent BioPharma Ltd. Placing to Raise US$4,500,000
03:00pm, Monday, 06'th Jan 2025
PERTH, Australia , Jan. 6, 2025 /PRNewswire/ -- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company addressing unmet medical needs by developing innovative treatmen
Royce Global Trust, Inc. (NYSE-RGT) declares Year-end Common Stock Distribution of $0.47 Per Share
04:00pm, Monday, 02'nd Dec 2024
NEW YORK , Dec. 2, 2024 /PRNewswire/ -- Royce Global Trust, Inc. (NYSE-RGT) (the "Fund") has declared a year-end distribution of $0.47 per share on its Common Stock. The distribution, optionally pay
Royce Global Trust (NYSE: RGT) as of Oct 31, 2024
11:48am, Wednesday, 20'th Nov 2024
NEW YORK , Nov. 20, 2024 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 27,933 shares Fund's advise
Royce Global Trust (NYSE: RGT) as of Sep 30, 2024
12:46pm, Monday, 28'th Oct 2024
NEW YORK , Oct. 28, 2024 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 28,421 shares Fund's advi
Royce Global Trust (NYSE: RGT) as of Jul 31, 2024
12:39pm, Wednesday, 28'th Aug 2024
NEW YORK , Aug. 28, 2024 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 23,890 shares Fund's advise
Royce Global Trust (NYSE: RGT) as of Apr 30, 2024
02:35pm, Tuesday, 28'th May 2024
NEW YORK , May 28, 2024 /PRNewswire/ -- A closed-end fund that invests in global equities using a disciplined value approach Average weekly trading volume of approximately 48,212 shares Fund's adviser
Sign In
Buy RGT